Pathogenesis of psoriasis

Journal of Dermatology

Volumn 25, Issue 12, 1998, Pages 778-781

  Barker, Jonathan N W N ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; CYCLOSPORIN A; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 2; PHOSPHORYLASE; RETINOID; VASCULOTROPIN; VITAMIN D;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL FEATURE; CONFERENCE PAPER; CROSS REACTION; ERYTHRODERMA; HEALTH ECONOMICS; HELPER CELL; IMMUNOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; PREVALENCE; PSORIASIS; QUALITY OF LIFE; SUPPRESSOR CELL;

EID: 0032453851     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02504.x     Document Type: Conference Paper

References (19)

1. Finlay AY, Coles EC: The effect of severe psoriasis on the quality of life of 369 patients, Br J Dermatol, 132: 236-244, 1995.
2. Barker JN: The pathophysiology of psoriasis, Lancet, 338: 227-230, 1991.
3. Folkman J, Shing Y: Angiogenesis, J Biol Chem, 267: 10931-10934, 1992.
4. Creamer D, Allen MH, Sousa A, Poston R, Barker JNWN: Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis, Br J Dermatol, 136: 859-865, 1997.
5. Creamer D, Allen MH, Groves RW, Barker JNWN: Circulating vascular permeability factor/vascular endothelium growth factor in erythroderma, Lancet, 348: 1101, 1996.
6. Griffiths CE, Voorhees JJ: Psoriasis, T cells and autoimmunity, Journal of the Royal Society of Medicine, 89: 315-319, 1996.
7. Wrone-Smith T, Nickoloff BJ: Dermal injection of immunocytes induces psoriasis, Journal of Clinical Investigation, 98: 1878-1887, 1996.
8. Baker BS, Swain AF, Fry L, Valdimarsson H: Epidermal T lymphocytes and HLA-DR expression in psoriasis, Br J Dermatol, 110: 555-564, 1984.
9. Gottlieb SL, Gilleaudeau P, Johnson R, et al: Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis, Nature Med, 1: 442-447, 1995.
10. Trembath RC, Clough RL, Rosbotham JL, et al: Identification of a major susceptibility gene locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis, Human Mol Genet, 6: 813-820, 1997.
11. Barker JN, Karabin GD, Stoof TJ, Sarma VJ, Dixit VM, Nickoloff BJ: Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction, Journal of Dermatological Science, 2: 106-111, 1991.
12. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia, J Invest Dermatol, 105: 89s-94s, 1995.
13. Barker JN, Goodlad JR, Ross EL, Yu CC, Groves RW, MacDonald DM: Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-gamma, Am J Pathol, 142: 1091-1097, 1993.
14. Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ: Bacterial super-antigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production, Journal of Experimental Medicine, 181: 747-753, 1995.
15. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L: Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal super-antigens?, Immunology Today, 16: 145-149, 1995.
16. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ: The genetics of psoriasis, Arch Dermatol, 130: 216-224, 1994.
17. Tomfohrde J, Silverman A, Barnes R, et al: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q, Science, 264: 1141-1145, 1994.
18. Matthews D, Fry L, Powles A, et al: Evidence that a locus for familial psoriasis maps to chromosome 4q, Nature Genetics, 14: 231-233, 1996.
19. Nair RP, Henseler T, Jenisch S, et al: Evidence for two psoriasis susceptibility loci (HLA ad 17q) and two novel candidate regions (16q and 20p) by genome-wide scan, Human Mol Genet, 6: 1349-1356, 1997.